CLASS II ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report

Olmesartan Medoxomil, Amlodipine recalled by Macleods Pharma USA

Macleods Pharma USA is recalling Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, distributed nationwide in the US. The recall was initiated on 7 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027
NDC33342-243, 33342-244, 33342-245, 33342-246, 33342-247
UPC0333342247070, 0333342245076
Quantity recalled3528 30-count and 216 90-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0077-2027
FDA event ID
100113
Recalling firm
Macleods Pharma USA, Princeton, NJ
Manufacturer
Macleods Pharmaceuticals Limited
Classification
Class II
Status
Ongoing
Recall initiated
7 Oct 2026
FDA classified
26 Oct 2026
Reported
4 Nov 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

7 Oct 2026Recall initiated by company
26 Oct 2026Classified by FDA+19 days
4 Nov 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications.

Which lots are affected?

Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Macleods Pharma USA

All 35